These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4552782

  • 21. Positive and negative control of R-factor replication in Proteus mirabilis.
    Punch JD, Kopecko DJ.
    J Bacteriol; 1972 Jan; 109(1):336-49. PubMed ID: 4550672
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].
    Sekowska A, Janicka G, Wróblewska J, Kruszyńska E.
    Pol Merkur Lekarski; 2004 Nov; 17(101):538-40. PubMed ID: 15754653
    [Abstract] [Full Text] [Related]

  • 26. [Sensitivity of different Proteus species to antibiotics].
    Dikiĭ BN.
    Antibiotiki; 1971 Jul; 16(7):622-4. PubMed ID: 4945575
    [No Abstract] [Full Text] [Related]

  • 27. [Sensitivity of clinical Proteus strains to antibiotics and their combinations].
    Sheina EP, Arutcheva AA.
    Antibiotiki; 1978 May; 23(5):424-8. PubMed ID: 350143
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Round of replication mutant of a drug resistance factor.
    Morris CF, Hashimoto H, Mickel S, Rownd R.
    J Bacteriol; 1974 Jun; 118(3):855-66. PubMed ID: 4598007
    [Abstract] [Full Text] [Related]

  • 33. The molecular nature and replication of drug resistance factors of the Enterobacteriaceae.
    Rownd R, Kasamatsu H, Mickel S.
    Ann N Y Acad Sci; 1971 Jun 11; 182():188-206. PubMed ID: 4936662
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E, Neuwirth C.
    J Antimicrob Chemother; 2011 Nov 11; 66(11):2513-20. PubMed ID: 21846670
    [Abstract] [Full Text] [Related]

  • 36. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A, Iyoda T, Matsuzaki K, Saika T, Ikeda F, Ishii Y, Yamaguchi K, Kobayashi I.
    Int J Antimicrob Agents; 2010 Oct 11; 36(4):340-2. PubMed ID: 20609568
    [Abstract] [Full Text] [Related]

  • 37. [Antibiotic policy and bacterial resistance].
    Snijder JA.
    Ned Tijdschr Geneeskd; 1978 Dec 16; 122(50):1958-62. PubMed ID: 364322
    [No Abstract] [Full Text] [Related]

  • 38. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R, Okugawa S, Kumita W, Sato K, Chida T, Okamura N, Moriya K, Koike K.
    Clin Microbiol Infect; 2007 Dec 16; 13(12):1204-6. PubMed ID: 17850340
    [Abstract] [Full Text] [Related]

  • 39. Studies on heavy-metal resistance in clinical isolates of Proteus mirabilis.
    Nakahara H, Asakawa M, Yonekura I, Sato A, Ohshima K, Kitamura M.
    Nihon Eiseigaku Zasshi; 1984 Dec 16; 39(5):812-8. PubMed ID: 6398376
    [No Abstract] [Full Text] [Related]

  • 40. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep 16; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.